Creative Biolabs-Immuno-oncology

Anti-DNM2 (clone 2E7J/DyDII) SynExpress E1-G-L/T-E Modified CD8+ T cells (CAT#: ITS-1224-CR2202)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DNM2 (clone 2E7J/DyDII). We employs the HBV (EF1α-GFP-LEF/TCF-EcoRI) vector components and the SynExpress system of the miRNA Knockout/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DNM2
Clone
2E7J/DyDII
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
EF1α
Effector Gene
LEF/TCF
Insertion Sites
EcoRI
Gene Modification
Knockout
Modification Domain
miRNA
Carrier Type
HBV
Transformation Accuracy
0.95
Cell Culture
Adherent Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.